Effect of noradrenaline and isoproterenol on lipopolysaccharide-induced tumor necrosis factor-alpha production in whole blood from patients with chronic heart failure and the role of beta-adrenergic receptors

American Journal of Cardiology

Volumn 95, Issue 7, 2005, Pages 885-889

  Von Haehling, Stephan ^a   Genth Zotz, Sabine ^b   Bolger, Aidan P ^b   Kalra, Paul R ^b   Kemp, Michael ^b   Adcock, Ian M ^b   Poole Wilson, Philip A ^b   Dietz, Rainer ^b   Anker, Stefan D ^b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL FUMARATE; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOPRENALINE; LIPOPOLYSACCHARIDE; METOPROLOL TARTRATE; NORADRENALIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HEART FAILURE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN INDUCTION;

EID: 15244338727     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.12.022     Document Type: Article

References (19)

1. A. Severn, N.T. Rapson, C.A. Hunter, F.Y. Liew Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists J Immunol 148 1992 3441 3445
2. T. van der Poll, S.M. Coyle, K. Barbosa, C.C. Braxton, S.F. Lowry Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia J Clin Invest 97 1996 713 719
3. X. Guirao, A. Kumar, J. Katz, M. Smith, E. Lin, C. Keogh, S.E. Calvano, S.F. Lowry Catecholamines increase monocyte TNF receptors and inhibit TNF through beta 2-adrenoreceptor activation Am J Physiol 273 1997 E1203 E1208
4. 2-agonists on resident and infiltrating inflammatory cells J Allergy Clin Immunol 110 2002 S282 S290
5. S.B. Liggett Update on current concepts of the molecular basis of β2-adrenergic receptor signaling J Allergy Clin Immunol 110 2002 S223 S228
6. M.J. Lohse, S. Engelhardt, T. Eschenhagen What is the role of beta-adrenergic signaling in heart failure? Circ Res 93 2003 896 906
7. D.M. Mancini, M.J. Frey, D. Fischberg, P.B. Molinoff, J.R. Wilson Characterization of lymphocyte beta-adrenergic receptors at rest and during exercise in ambulatory patients with chronic congestive heart failure Am J Cardiol 63 1989 307 312
8. S. Ishida, N. Makino, K. Masutomo, T. Hata, T. Yanaga Effect of metoprolol on the beta-adrenoceptor density of lymphocytes in patients with dilated cardiomyopathy Am Heart J 125 1993 1311 1315
9. J.R. Wu, H.R. Chang, T.Y. Huang, C.H. Chiang, S.S. Chen Reduction in lymphocyte beta-adrenergic receptor density in infants and children with heart failure secondary to congenital heart disease Am J Cardiol 77 1996 170 174
10. CIBIS-II Investigators and Committees The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial Lancet 353 1999 9 13
11. MERIT-Heart Failure Study Group Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) Lancet 353 1999 2001 2007
12. M. Packer, A.J. Coats, M.B. Fowler, H.A. Katus, H. Krum, P. Mohacsi, J.L. Rouleau, M. Tendera, A. Castaigne, E.B. Roecker Effect of carvedilol on survival in severe chronic heart failure N Engl J Med 344 2001 1651 1658
13. M. Packer, M.R. Bristow, J.N. Cohn, W.S. Colucci, M.B. Fowler, E.M. Gilbert, N.H. Shusterman The effect of carvedilol on morbidity and mortality in patients with chronic heart failure U.S. Carvedilol Heart Failure Study Group N Engl J Med 334 1996 1349 1355
14. S.D. Anker, K.R. Egerer, H.D. Volk, W.J. Kox, P.A. Poole-Wilson, A.J.S. Coats Elevated soluble CD14 receptors and altered cytokines in chronic heart failure Am J Cardiol 79 1997 1426 1430
15. S.D. Anker, S. von Haehling Inflammatory mediators in chronic heart failure: an overview Heart 90 2004 464 470
16. S. von Haehling, E.A. Jankowska, S.D. Anker Tumour necrosis factor-a and the failing heart: pathophysiology and therapeutic implications Basic Res Cardiol 99 2004 18 28
17. K. Brixius, A. Bundkirchen, B. Bolck, U. Mehlhorn, R.H. Schwinger Nebivolol, bucindolol, metoprolol and carvedilol are devoid of intrinsic sympathomimetic activity in human myocardium Br J Pharmacol 133 2001 1330 1338
18. S. Genth-Zotz, S. von Haehling, A.P. Bolger, P.R. Kalra, R. Wensel, A.J.S. Coats, S.D. Anker Pathophysiological quantities of endotoxin induce tumor necrosis factor release in whole blood from patients with chronic heart failure Am J Cardiol 90 2002 1226 1230
19. J.F. Tohmeh, P.E. Cryer Biphasic adrenergic modulation of beta-adrenergic receptors in man Agonist-induced early increment and late decrement in beta-adrenergic receptor number J Clin Invest 65 1980 836 840